G / TRY

G / USDT

PEPE / JPY

PEPE / USDC

PEPE / EUR

PEPE / USDT

PEPE / USD1

PEPE / TRY

PEPE / FDUSD

PEPE / BRL

SHELL / TRY

REZ / USDC

COS / TRY

REZ / USDT

COS / USDT

KITE / USDT

REZ / TRY

KITE / TRY

KITE / USDC

SHELL / USDC

AKI INDIA LIMITED

HAPPY SQUARE OUTSOURC S L

GANGA BATH FITTINGS LTD

BAJEL PROJECTS LIMITED

DCM SHRIRAM INTERNATNL L

ONYX BIOTEC LIMITED

MRPL

ITI LTD

DIVINE POWER ENERGY LTD

DCM FINANCIAL SERVICES LT

IDBI BANK LIMITED

OIL COUNTRY TUBULAR LTD.

HINDUSTAN OIL EXPLORATION

HPL ELECTRIC & POWER LTD

FINO PAYMENTS BANK LTD

CONFIDENCE PETRO IND LTD.

DSPAMC - MIDCAPADD

FIDEL SOFTECH LIMITED

SATTVA ENGINEERING CSTN L

PRANIK LOGISTICS LIMITED

Click here to get full coverage on Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals - Markets Mojo

Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals  Markets Mojo

Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals - Markets Mojo

Click here to get full coverage on Alkem Labs receives GMP certificate from German authority for Baddi facility - Business Standard

Alkem Labs receives GMP certificate from German authority for Baddi facility  Business Standard

Alkem Labs receives GMP certificate from German authority for Baddi facility - Business Standard

Click here to get full coverage on Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility - Medical Dialogues

Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility  Medical Dialogues

Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility - Medical Dialogues

Click here to get full coverage on Alkem Laboratories - Negative Breakout: These 12 stocks cross below their 200 DMAs - The Economic Times

Alkem Laboratories - Negative Breakout: These 12 stocks cross below their 200 DMAs  The Economic Times

Alkem Laboratories - Negative Breakout: These 12 stocks cross below their 200 DMAs - The Economic Times

Click here to get full coverage on Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd. - Yahoo Finance

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.  Yahoo Finance

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd. - Yahoo Finance

Click here to get full coverage on Esperion and Alkem Laboratories Settle Patent Litigation Over NEXLETOL and NEXLIZET | ESPR Stock News - Quiver Quantitative

Esperion and Alkem Laboratories Settle Patent Litigation Over NEXLETOL and NEXLIZET | ESPR Stock News  Quiver Quantitative

Esperion and Alkem Laboratories Settle Patent Litigation Over NEXLETOL and NEXLIZET | ESPR Stock News - Quiver Quantitative

Click here to get full coverage on Amgen Commences 11th BPCIA Denosumab Litigation Against Alkem - Pearce IP

Amgen Commences 11th BPCIA Denosumab Litigation Against Alkem  Pearce IP

Amgen Commences 11th BPCIA Denosumab Litigation Against Alkem - Pearce IP

Click here to get full coverage on Alkem Laboratories Limited Receives Certificate of GMP Compliance of a Manufacturer For Manufacturing Facility Located At Baddi, India from Department of Pharmacy (Human Medicines) ? Germany - marketscreener.com

Alkem Laboratories Limited Receives Certificate of GMP Compliance of a Manufacturer For Manufacturing Facility Located At Baddi, India from Department of Pharmacy (Human Medicines) ? Germany  marketscreener.com

Alkem Laboratories Limited Receives Certificate of GMP Compliance of a Manufacturer For Manufacturing Facility Located At Baddi, India from Department of Pharmacy (Human Medicines) ? Germany - marketscreener.com

Click here to get full coverage on Axsome, Alkem strike deal setting 2040 start for U.S. SUNOSI generic - Stock Titan

Axsome, Alkem strike deal setting 2040 start for U.S. SUNOSI generic  Stock Titan

Axsome, Alkem strike deal setting 2040 start for U.S. SUNOSI generic - Stock Titan

Click here to get full coverage on Esperion settles patent dispute with Alkem over cholesterol drugs - Investing.com

Esperion settles patent dispute with Alkem over cholesterol drugs  Investing.com

Esperion settles patent dispute with Alkem over cholesterol drugs - Investing.com

Click here to get full coverage on Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility - scanx.trade

Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility  scanx.trade

Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility - scanx.trade

Click here to get full coverage on Does Alkem Laboratories (NSE:ALKEM) Deserve A Spot On Your Watchlist? - simplywall.st

Does Alkem Laboratories (NSE:ALKEM) Deserve A Spot On Your Watchlist?  simplywall.st

Does Alkem Laboratories (NSE:ALKEM) Deserve A Spot On Your Watchlist? - simplywall.st

Click here to get full coverage on Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals - Markets Mojo

Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals  Markets Mojo

Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals - Markets Mojo

Click here to get full coverage on ALKEM Stock Price and Chart — NSE:ALKEM - TradingView

ALKEM Stock Price and Chart — NSE:ALKEM  TradingView

ALKEM Stock Price and Chart — NSE:ALKEM - TradingView

Click here to get full coverage on India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million - Yahoo Finance Singapore

India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million  Yahoo Finance Singapore

India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million - Yahoo Finance Singapore

Click here to get full coverage on Delhi High Court denies interim protection to Alkem in 'A to Z' trademark case - The Economic Times

Delhi High Court denies interim protection to Alkem in 'A to Z' trademark case  The Economic Times

Delhi High Court denies interim protection to Alkem in 'A to Z' trademark case - The Economic Times

Click here to get full coverage on Alkem Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals - Markets Mojo

Alkem Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals  Markets Mojo

Alkem Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals - Markets Mojo

Click here to get full coverage on Alkem Laboratories introduces hair growth support therapy kit - The Economic Times

Alkem Laboratories introduces hair growth support therapy kit  The Economic Times

Alkem Laboratories introduces hair growth support therapy kit - The Economic Times

Click here to get full coverage on Alkem Laboratories Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals - Markets Mojo

Alkem Laboratories Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals  Markets Mojo

Alkem Laboratories Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals - Markets Mojo

Click here to get full coverage on Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories - EY

Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories  EY

Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories - EY

Click here to get full coverage on PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent - VitalLaw.com

PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent  VitalLaw.com

PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent - VitalLaw.com

Click here to get full coverage on Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India - ET Pharma

Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India  ET Pharma

Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India - ET Pharma

Click here to get full coverage on Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up - simplywall.st

Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up  simplywall.st

Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up - simplywall.st

Click here to get full coverage on Alkem Arm Makes Binding Offer to Acquire 51-55% Stake in Swiss Medtech Firm Occlutech - Medical Dialogues

Alkem Arm Makes Binding Offer to Acquire 51-55% Stake in Swiss Medtech Firm Occlutech  Medical Dialogues

Alkem Arm Makes Binding Offer to Acquire 51-55% Stake in Swiss Medtech Firm Occlutech - Medical Dialogues

Click here to get full coverage on Alkem's Enzene powers into US with $70 m investment - The Economic Times

Alkem's Enzene powers into US with $70 m investment  The Economic Times

Alkem's Enzene powers into US with $70 m investment - The Economic Times

Click here to get full coverage on ‘No monopoly on alphabet’: Delhi High Court denies pharma giant Alkem protection for ‘A TO Z’ mark - The Indian Express

‘No monopoly on alphabet’: Delhi High Court denies pharma giant Alkem protection for ‘A TO Z’ mark  The Indian Express

‘No monopoly on alphabet’: Delhi High Court denies pharma giant Alkem protection for ‘A TO Z’ mark - The Indian Express

Click here to get full coverage on Alkem Labs Q2 Results: Strong India, US sales lift revenue; profit, margins improve - CNBC TV18

Alkem Labs Q2 Results: Strong India, US sales lift revenue; profit, margins improve  CNBC TV18

Alkem Labs Q2 Results: Strong India, US sales lift revenue; profit, margins improve - CNBC TV18

Click here to get full coverage on Alkem Q2 FY26 revenue rises 17% to Rs 4000 cr on strong international sales - ET Pharma

Alkem Q2 FY26 revenue rises 17% to Rs 4000 cr on strong international sales  ET Pharma

Alkem Q2 FY26 revenue rises 17% to Rs 4000 cr on strong international sales - ET Pharma

Click here to get full coverage on Alkem Laboratories Ltd Technical Momentum Shifts Amid Sideways Trend - Markets Mojo

Alkem Laboratories Ltd Technical Momentum Shifts Amid Sideways Trend  Markets Mojo

Alkem Laboratories Ltd Technical Momentum Shifts Amid Sideways Trend - Markets Mojo

Click here to get full coverage on Alkem Labs unit to buy up to 55% of Occlutech for $118 million - The Economic Times

Alkem Labs unit to buy up to 55% of Occlutech for $118 million  The Economic Times

Alkem Labs unit to buy up to 55% of Occlutech for $118 million - The Economic Times

Click here to get full coverage on Alkem Laboratories Faces Challenges Amid Flat Financial Performance and Reduced Promoter Confidence - Markets Mojo

Alkem Laboratories Faces Challenges Amid Flat Financial Performance and Reduced Promoter Confidence  Markets Mojo

Alkem Laboratories Faces Challenges Amid Flat Financial Performance and Reduced Promoter Confidence - Markets Mojo

Click here to get full coverage on Alkem Laboratories Subsidiary Executes Share Purchase Agreement for Occlutech - scanx.trade

Alkem Laboratories Subsidiary Executes Share Purchase Agreement for Occlutech  scanx.trade

Alkem Laboratories Subsidiary Executes Share Purchase Agreement for Occlutech - scanx.trade

Click here to get full coverage on Alkem Laboratories Ltd is Rated Hold by MarketsMOJO - Markets Mojo

Alkem Laboratories Ltd is Rated Hold by MarketsMOJO  Markets Mojo

Alkem Laboratories Ltd is Rated Hold by MarketsMOJO - Markets Mojo

Click here to get full coverage on Alkem Laboratories First Quarter 2026 Earnings: Beats Expectations - simplywall.st

Alkem Laboratories First Quarter 2026 Earnings: Beats Expectations  simplywall.st

Alkem Laboratories First Quarter 2026 Earnings: Beats Expectations - simplywall.st

Click here to get full coverage on Alkem introduces advanced ceramide-boosting product for skin barrier repair - BioSpectrum India

Alkem introduces advanced ceramide-boosting product for skin barrier repair  BioSpectrum India

Alkem introduces advanced ceramide-boosting product for skin barrier repair - BioSpectrum India

Click here to get full coverage on Alkem MedTech to acquire majority stake in Swiss firm Occlutech Holding for Rs 1074 Cr - BioSpectrum India

Alkem MedTech to acquire majority stake in Swiss firm Occlutech Holding for Rs 1074 Cr  BioSpectrum India

Alkem MedTech to acquire majority stake in Swiss firm Occlutech Holding for Rs 1074 Cr - BioSpectrum India

Click here to get full coverage on Why these healthcare stocks Piramal Pharma, Alkem Lab, Natco, Zydus will be in focus on Monday (Feb 16) - BusinessLine

Why these healthcare stocks Piramal Pharma, Alkem Lab, Natco, Zydus will be in focus on Monday (Feb 16)  BusinessLine

Why these healthcare stocks Piramal Pharma, Alkem Lab, Natco, Zydus will be in focus on Monday (Feb 16) - BusinessLine

Click here to get full coverage on Alkem Labs shares slump over 8% despite record interim dividend - CNBC TV18

Alkem Labs shares slump over 8% despite record interim dividend  CNBC TV18

Alkem Labs shares slump over 8% despite record interim dividend - CNBC TV18

Click here to get full coverage on Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2... - Medical Dialogues

Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2...  Medical Dialogues

Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2... - Medical Dialogues

Click here to get full coverage on Alkem Laboratories introduces DSS Probiotic in India to boost gut health - Business Standard

Alkem Laboratories introduces DSS Probiotic in India to boost gut health  Business Standard

Alkem Laboratories introduces DSS Probiotic in India to boost gut health - Business Standard

Click here to get full coverage on Alkem Labs' Chakan facility gets six observations in USFDA inspection, no data integrity issues - The Economic Times

Alkem Labs' Chakan facility gets six observations in USFDA inspection, no data integrity issues  The Economic Times

Alkem Labs' Chakan facility gets six observations in USFDA inspection, no data integrity issues - The Economic Times

Click here to get full coverage on Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year - CNBC TV18

Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year  CNBC TV18

Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year - CNBC TV18

Click here to get full coverage on Reduce Alkem Labs; target of Rs 5850: Choice Institutional Equities - Moneycontrol.com

Reduce Alkem Labs; target of Rs 5850: Choice Institutional Equities  Moneycontrol.com

Reduce Alkem Labs; target of Rs 5850: Choice Institutional Equities - Moneycontrol.com

Click here to get full coverage on Alkem Labs Q2 profit rises 11% to Rs 779 crore - Moneycontrol.com

Alkem Labs Q2 profit rises 11% to Rs 779 crore  Moneycontrol.com

Alkem Labs Q2 profit rises 11% to Rs 779 crore - Moneycontrol.com

Click here to get full coverage on Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal - Moneycontrol.com

Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal  Moneycontrol.com

Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal - Moneycontrol.com

Click here to get full coverage on Alkem's Enzene Unit Gets 6 USFDA Observations - Medical Dialogues

Alkem's Enzene Unit Gets 6 USFDA Observations  Medical Dialogues

Alkem's Enzene Unit Gets 6 USFDA Observations - Medical Dialogues

Click here to get full coverage on Alkem Laboratories Senior VP Rakesh Tripathi Steps Down After 8.7-Year Tenure - scanx.trade

Alkem Laboratories Senior VP Rakesh Tripathi Steps Down After 8.7-Year Tenure  scanx.trade

Alkem Laboratories Senior VP Rakesh Tripathi Steps Down After 8.7-Year Tenure - scanx.trade

Click here to get full coverage on Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal - Moneycontrol.com

Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal  Moneycontrol.com

Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal - Moneycontrol.com

Click here to get full coverage on Alkem Foundation ties with IIT-B to set up R&D centre for developing immuno therapies - ET Pharma

Alkem Foundation ties with IIT-B to set up R&D centre for developing immuno therapies  ET Pharma

Alkem Foundation ties with IIT-B to set up R&D centre for developing immuno therapies - ET Pharma

Click here to get full coverage on Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics - Markets Mojo

Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics  Markets Mojo

Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics - Markets Mojo

Click here to get full coverage on Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet - Medical Dialogues

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet  Medical Dialogues

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet - Medical Dialogues

Click here to get full coverage on Alkem Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns - Markets Mojo

Alkem Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns  Markets Mojo

Alkem Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns - Markets Mojo

Click here to get full coverage on Alkem Laboratories' Daman Facility Passes Malta GMP Inspection With Zero Critical Issues - scanx.trade

Alkem Laboratories' Daman Facility Passes Malta GMP Inspection With Zero Critical Issues  scanx.trade

Alkem Laboratories' Daman Facility Passes Malta GMP Inspection With Zero Critical Issues - scanx.trade

Click here to get full coverage on Alkem Labs Q2 profit rises 11% on strong India, international sales - Business Standard

Alkem Labs Q2 profit rises 11% on strong India, international sales  Business Standard

ALKEM

Price Chart

Key Statistics

Technicals

About ALKEM

Latest News

Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals - Markets Mojo

Alkem Labs receives GMP certificate from German authority for Baddi facility - Business Standard

Alkem Laboratories Receives EU GMP Certificate for Baddi Manufacturing Facility - Medical Dialogues

Advanced Charts

Top Gainers

Top Losers